21 Invest completed the acquisition of a majority stake in Rocamed from Promepla.

Synopsis

21 Invest, a growth equity firm, completed the acquisition of a majority stake in Rocamed, a medical device company, from Promepla, a pharmaceutical manufacturing, manufacturing general, and manufacturing company. Financial terms were not disclosed.

Principals

target

ROCAMED

bidder

21 Invest

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

olivier jaigu

Chairman and CEO at ROCAMED

Manager

target

Deal

n/a

Total Value

Bidder Team (1)

francois barbier

Managing Partner and CEO at 21 INVEST

Investor

bidder

Deals

£ 41 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy